Firm Inks Deal to Deliver Medicines and Covid19 Test Kits and Supplies in BC, Alberta and Ontario
Source: Streetwise Reports  (3/13/20)
ParcelPal Technology reported that it has signed an agreement to deliver pharmaceuticals and Covid19 supplies including test kits in three areas of Canada with the potential of reaching more than 40 pharmacies nationwide. More >

OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility
Source: Streetwise Reports  (3/13/20)
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast. More >

Predictive Oncology Launches AI Vaccine and Drug Platform & Acquires Technology
Source: Streetwise Reports  (3/12/20)
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology. More >

Surgical Imaging Firm Reports Positive Physician Response to Bladder Cancer Visualization System
Source: Streetwise Reports  (3/11/20)
Imagin Medical announced on-going research feedback on its i/Blueâ„¢ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures. More >

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses
Source: Streetwise Reports  (3/11/20)
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. More >

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test
Source: Streetwise Reports  (3/10/20)
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. More >

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment
Source: Streetwise Reports  (3/9/20)
Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. More >

Digital Health & Telemedicine Firm Increases Doctor Onboarding Amid Coronavirus Worries
Source: Streetwise Reports  (3/9/20)
CloudMD reported it's accelerating onboarding of physicians amid rising COVID-19 concerns. The firm also advised it is on track to close a new CA$3 million brokered financing on March 11, 2020. More >

U.S.-Based Biotech 'Growing into a Giant with AI'
Source: Streetwise Reports  (3/7/20)
How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. More >

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing
Source: Streetwise Reports  (3/6/20)
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. More >

Avivagen to Be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD on March 6
Source: Streetwise Reports  (3/5/20)
Webcast will be at 12 noon ET on Friday, March 6. More >

Antibody Developer Taken Out by Gilead at 'Hefty Premium'
Source: Streetwise Reports  (3/4/20)
The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. More >

Digital Health Firm to Place Telemedicine Kiosks in Pharmacy Consult Rooms
Source: Streetwise Reports  (3/4/20)
CloudMD announced it will be installing proprietary kiosks in participating pharmacies to enable on-demand telemedicine visits with licensed physicians. More >

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data
Source: Streetwise Reports  (3/4/20)
Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. More >

Telemedicine Platform Provider for Community-Based Healthcare Adds 50,000 Medicare Members
Source: Streetwise Reports  (3/3/20)
Reliq Health Technologies reported that it has signed a contract with Blum Telehealth to provide its iUGO Care software platform to over 50,000 Medicare patients in the state of Louisiana. More >

GenMark Shares Trade 30% Higher on Yearly Earnings and Increased SARS-CoV-2 Virus Detection Test Kit Shipments
Source: Streetwise Reports  (3/3/20)
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus. More >

Digital Health Firm Scales Up Telemedicine Services as Global Coronavirus Concerns Mount
Source: Streetwise Reports  (3/2/20)
CloudMD will be scaling up its freely accessible telemedicine app that allows patients to see a doctor in real-time using either a smartphone or desktop device. More >

Health Tech Firm to Service Sizable Home Healthcare Network
Source: Streetwise Reports  (3/2/20)
Reliq Health Technologies will provide its software and call center support. More >

Karyopharm Trades Up 60% on Positive Phase 3 Multiple Myeloma Results
Source: Streetwise Reports  (3/2/20)
Karyopharm Therapeutics shares set a new 52-week high price after the company reported that its Phase 3 BOSTON trial of XPOVIO® achieved significant increases in progression-free survival in patients suffering with multiple myeloma. More >

Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration
Source: Streetwise Reports  (2/28/20)
Sangamo Therapeutics shares traded higher after the company reported Q4/19 and FY/19 earnings and advised that it signed a global collaboration agreement with Biogen to develop gene regulation therapies for Alzheimer's, Parkinson's, neuromuscular and neurological diseases. More >

Teladoc Shares Trade 20% Higher on Virtual Medicine Tailwinds and Q4 Earnings
Source: Streetwise Reports  (2/27/20)
Shares of Teladoc Health climbed to a new 52-week high price after the firm reported Q4/19 and FY/19 financial results that included a 32% year-over-year increase in revenue and a 57% increase in patient visits. More >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports  (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. More >

Mobile Health and Telemedicine Provider for Community-Based Healthcare Teams Up with US Health Data Firm
Source: Streetwise Reports  (2/26/20)
Reliq Health Technologies advised that it has been selected as remote patient monitoring and chronic care management solutions partner by U.S. health data company MaxMD. More >

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study
Source: Streetwise Reports  (2/25/20)
Shares of Moderna traded 23% higher after the company reported that it has developed and shipped an mRNA vaccine against novel coronavirus for use in a Phase 1 testing study in the U.S. More >

Two Stock-Moving Catalysts Expected in March for Biopharma
Source: Streetwise Reports  (2/25/20)
These events for Axsome Therapeutics are described in an H.C. Wainwright & Co. report. More >